Rationale: Combination muscarinic antagonist (MA) − β2−adrenoceptor agonist (BA) bronchodilator therapy may provide additional clinical benefits in patients with COPD (van Noord, 2005). Combivent, a co−formulation of muscarinic antagonist (MA; ipratropium) and β2−adrenergic agonist (BA; albuterol), requires dosing every 6−8 h. Here, we characterized the in vivo bronchodilatory effect of a bifunctional MABA, TD−5959, in a guinea pig (GP) model of bronchoprotection. Methods: Conscious GPs were dosed by inhalation with nebulized aqueous solutions of vehicle or TD−5959 for 10 min. GPs were anesthetized, tracheotomized and ventilated before changes in ventilation pressure induced by either methacholine (MCh) ± propranolol (for MA or MABA activity, respectively) or histamine (HA) (for BA activity) were measured. Inhibition (%) of MCh or HA bronchoconstrictive response relative to the vehicle−treated groups were calculated. Results: Inhaled TD−5959 dose−dependently inhibited both MCh (± propranolol) and HA−induced bronchoconstriction. The onset of action was < 1.5 hr (the earliest time point tested) and the estimated bronchoprotective inhibitory potency (ID50) was 33.9 µg/mL for MA and 14.1 µg/mL for BA. Against HA challenge, bronchoprotection by TD−5959 (30 µg/mL) was completely blocked by propranolol confirming the BA mechanism. Dual pharmacology yielded bronchoprotection that was 2−5 fold more potent (MABA ID50 = 6.4 µg/mL) than either MA or BA alone. This MABA effect of TD−5959 was observed for up to 24 h after inhalation. Conclusion: TD−5959 is a novel bifunctional molecule that confers potent 24 h bronchoprotection in GPs through a dual mechanism involving antagonism of muscarinic receptors and agonism of β2−adrenoceptors. TD−5959 exemplifies a new class of bronchodilators with the potential to improve on the existing treatments for COPD. This abstract is funded by: Theravance, Inc. Am J Respir Crit Care Med 179;2009:A6195 Internet address: www.atsjournals.org Online Abstracts Issue
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.